PP
RAPT

PDT Partners’s RAPT Therapeutics RAPT Stock Holding History

PDT Partners’s Portfolio RAPT Stock Details RAPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4,625
Closed -$74.4K – 808
2024
Q3 		$74.4K Sell
4,625
-7,601
-62% -$154K 0.01% 701
2024
Q2 		$298K Buy
+12,226
New +$565K 0.03% 551
2021
Q3 		– Sell
-2,175
Closed -$553K – 884
2021
Q2 		$553K Sell
2,175
-1,695
-44% -$317K 0.04% 498
2021
Q1 		$687K Buy
3,870
+2,581
+200% +$426K 0.05% 448
2020
Q4 		$204K Buy
+1,289
New +$280K 0.01% 609

Other funds holding RAPT

MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PDT Partners's RAPT Position: Q4 2024 in Review

PDT Partners sold out of RAPT Therapeutics (RAPT) in Q4 2024, closing a stake of 4,625 shares — an estimated $74.4K sold.

PDT Partners first reported a position in RAPT in Q4 2020 and held it in 5 quarters. The position peaked at $687K in Q1 2021. 91 funds tracked by Wall St. Rank hold RAPT as of Q4 2024.

  • PDT Partners reported no remaining RAPT Therapeutics position as of Q4 2024 after selling out during the quarter.
  • PDT Partners sold 4,625 RAPT Therapeutics shares in Q4 2024, an estimated $74.4K.
  • PDT Partners first reported a position in RAPT Therapeutics in Q4 2020 and held it in 5 quarters.
  • PDT Partners's RAPT Therapeutics position peaked at $687K in Q1 2021.
  • 91 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q4 2024.

Based on PDT Partners's 13F filing for Q4 2024, filed 14 Feb 2025.